Compositions for sleeping disorders

• US 7,935,714 B2
• Filed: 05/13/2005
• Issued: 05/03/2011
• Est. Priority Date: 05/18/2004
• Status: Active Grant

• Current Assignee: Bright Future Pharmaceutical Laboratories Ltd.
• Original Assignee: Bright Future Pharmaceutical Laboratories
• Inventors: Rowlands, Dewi Kenneth, Chan, Hsiao Chang, Gou, Yu Lin, Chung, Yiu Wa
• Primary Examiner(s): Padmanabhan; Sreeni
• Assistant Examiner(s): JEAN-LOUIS, SAMIRA JM
• Application Number:
  US11/129,628
• Publication Number:
  US 20050261167A1
• Time in Patent Office: 2,181 Days
• Field of Search: 514/312, 514/320, 514/456
• US Class Current: 514/312
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/352 condensed with carbocyclic rings, e.g. methantheline cannabinoids A61K31/658
• CPC Class Codes: A61K 31/353 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
• CPC Class Codes: A61K 31/452 Piperidinium derivatives pancuronium A61K31/58
• CPC Class Codes: A61K 31/4709 Non-condensed quinolines and containing further heterocyclic rings
• CPC Class Codes: A61K 31/7048 having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin , digitoxin or digoxin
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: A61P 21/02 Muscle relaxants, e.g. for tetanus or cramps
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 25/14 for treating abnormal movements, e.g. chorea, dyskinesia
• CPC Class Codes: A61P 25/16 Anti-Parkinson drugs
• CPC Class Codes: A61P 25/20 Hypnotics; Sedatives
• CPC Class Codes: A61P 25/24 Antidepressants
• CPC Class Codes: A61P 25/28 for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• CPC Class Codes: A61P 27/06 Antiglaucoma agents or miotics

Abstract

Provided herein is a composition that contains an effective amount of one or more compounds for treating, preventing, or ameliorating a disorder such as insomnia or another sleeping disorder and using the composition.

Claims

1. A composition comprising dihydromyricetin, myricetin, and myricitrin in a weight percentage ratio selected from the group consisting of 90.38:

7.77;

1.84, 95.14;

3.69;

1.23, and 75.46;

23.26;

1.27.

2. The composition of claim 1, wherein the weight ratio is 75.46:

23.26;

1.27.

3. The composition of claim 1, further comprising a pharmaceutically acceptable carrier.

4. The composition of claim 3, wherein the pharmaceutically acceptable carrier is a carrier suitable for oral delivery, parenteral delivery, topical delivery, mucosal delivery, intradermal delivery, intravenous injection, subcutaneous injection, intramedullary injection, administration by inhalation, and intranasal delivery.

5. The composition of claim 1 in a dosage form selected from the group consisting of a solution, a suspension, a syrup, a tablet, a capsule, microparticles, an ointment, a cream, and a lozenge.

6. The composition of claim 1, which is a pharmaceutical composition.

7. The composition of claim 1, which is a nutraceutical composition or dietary supplement composition.